Brain and Nervous System, Phase II

MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma

Volunteers
Health Professionals

What is the purpose of this trial?

This is an open-label, multicenter, randomized, phase 2 clinical study to evaluate the efficacy of [177Lu]Lu-DOTATATE in patients with progressive grade 1-3 intracranial meningioma.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Amy L. Rodrigues

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Sylvia Kurz, MD, PhD
Associate Professor of Neurology; Associate Professor of Neurology, Neuro-Oncology; Co-Director, Chênevert Family Brain Tumor Center

Sub-Investigators

Last Updated
04/16/2026
Study IRB
#2000041613